HIV, tuberculosis, and malaria: how can the impact of COVID-19 be minimised?

Type Journal Article Author Peter Sands URL https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(20)30317-X/abstract Series Comment Volume 8 Issue 9 Pages e1102-e1103 Publication The Lancet Global Health ISSN 2214-109X Date 13/07/2020 Extra Publisher: Elsevier PMID: 32673576 Journal Abbr The Lancet Global Health DOI 10.1016/S2214-109X(20)30317-X Library Catalog www.thelancet.com Language English Abstract In The Lancet Global Health, Alexandra Hogan and colleagues1 report the findings of a modelling study in which they estimate the number of excess deaths from HIV, tuberculosis, and malaria that could plausibly occur as a consequence of the COVID-19 pandemic. They conclude that, in high-burden settings, HIV, tuberculosis, and malaria deaths over a 5-year period could increase by 10%, 20%, and 36%, respectively, and that although the loss of life-years from this knock-on impact will probably be less than the direct impact of COVID-19, in high-burden countries, it could be of the same order of magnitude. Short Title HIV, tuberculosis, and malaria